Concepedia

Jason M. Foulks

JM

18

Publications

2.2K

Citations

17

H-Index

1948

Active since

Affiliations

University of Utah(Current)

Astex Pharmaceuticals

Sumitomo Dainippon Pharma (United States)

Tolero Pharmaceuticals (United States)

Cleveland Clinic Lerner College of Medicine

Jason M. Foulks is an author at University of Utah specializing in medicine, biochemistry, and pharmacology.

ORCID

Top concepts

Publications per year

1948–2023

18

Publications

18

An Epithelial–Mesenchymal Transition Gene Signature Predicts Resistance to EGFR and PI3K Inhibitors and Identifies Axl as a Therapeutic Target for Overcoming EGFR Inhibitor Resistance

Lauren A. Byers, Lixia Diao, Jing Wang et al. · Clinical Cancer Research · 2012 · 1.1K citations · Full text

Signal-dependent splicing of tissue factor pre-mRNA modulates the thrombogenecity of human platelets

Hansjörg Schwertz, Neal D. Tolley, Jason M. Foulks et al. · The Journal of Experimental Medicine · 2006 · 347 citations · Full text

mTOR-dependent synthesis of Bcl-3 controls the retraction of fibrin clots by activated human platelets

Andrew S. Weyrich, Melvin M. Denis, Hansjörg Schwertz et al. · Blood · 2006 · 133 citations · Full text

The Renal Excretion of Potassium.

Gilbert H. Mudge, Jason M. Foulks, Alfred G. Gilman · Experimental Biology and Medicine · 1948 · 91 citations

, , +15

A Small-Molecule Inhibitor of PIM Kinases as a Potential Treatment for Urothelial Carcinomas

Jason M. Foulks, Kent J. Carpenter, Bai Luo et al. · Neoplasia · 2014 · 89 citations · Full text

Rows per page

1–5 of 18